The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts. - Wikidata - wikimedia - TriplyDB

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

http://www.wikidata.org/entity/Q37519061

about

Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis.Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching.

P2860

Q41694184-0642DC60-B11F-4C76-B1B5-73803FAD2DE3 Q47444419-F23DF77A-E25E-44F1-82A4-D177FA04D674

P2860

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

http://www.wikidata.org/entity/Q37519061

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

@en

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

@nl

type

label

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

@en

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

@nl

prefLabel

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

@en

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

@nl

P1433

Q37519061-A28CE1DF-BE65-4E56-878F-B93C132B578B

P1476

Q37519061-339CACA4-9AD4-4169-BE00-85F3C641963E

P2093

Q37519061-45EC1C75-B562-4003-9536-6D7F77C4C160

Q37519061-56A69F97-A378-4590-BAA9-F81AF44889D8

Q37519061-5DD59669-CEF6-48EF-8818-D45332FC44A0

P2860

Q37519061-0917BDA7-9881-4F37-B022-AB20D4E0B2F8

Q37519061-21B7B11F-0D4A-4C31-8DEB-16EC198179E9

Q37519061-23DB09F3-D492-4225-A4F8-D99EBE1204FB

Q37519061-2677A496-8D7F-4F2A-B71E-443D0ED4FA03

Q37519061-33B769FA-B7FB-4690-AB89-C8D3BE274BC5

Q37519061-3438E552-6B87-4D68-ACBA-DA14A24F7576

Q37519061-3804341F-862E-4B89-9F95-DE542E9690C2

Q37519061-3954FFBD-A80D-47F5-9EB9-ECDE288A9C50

Q37519061-402D2CBA-A1A0-48CC-9710-F6862C1D79AE

Q37519061-4F79827D-2800-43C0-98AD-C7F1F51D21DA

P2888

Q37519061-363ACA60-E270-4520-B902-CE637216CE19

P304

Q37519061-1F870693-D23E-4FFC-82F5-A8E8B1F1E886

P31

Q37519061-794ACC2D-2F71-449D-8BDF-4AA51FB117A3

P356

Q37519061-4B1BD03B-144D-4202-8431-9AEC38042FC8

P407

Q37519061-45F71FF9-7ADA-42B6-9E06-F989A4EF6015

P478

Q37519061-A5926E5D-8748-4452-9A5D-97C5454F6C64

P50

Q37519061-3174ADD4-5A4D-46F5-83BF-C78509708E5E

Q37519061-DFA3AB9B-4A8C-49B3-A400-FD5CA9011559

P577

Q37519061-BEA151FD-8C54-4425-8E71-87BD8013B43E

P6179

Q37519061-9389DD2F-6492-4A26-B6D8-0C5C7AB2D377

P698

Q37519061-4F57A305-7A85-4D72-89B9-97675DE78E35

P921

Q37519061-633ABBA7-4B95-4114-B30A-FF8CC2EDC9A9

Q37519061-DFBD1529-12F0-41D3-932B-B29A6DA80163

P932

Q37519061-7B4570D0-A4BB-4779-AE26-E2AB24D05A7A

P356

P1433

Scientific Reports

P1476

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.

@en

P2093

Louis Dore-Savard

http://www.w3.org/2001/XMLSchema#string

Samata Kakkad

http://www.w3.org/2001/XMLSchema#string

Zaver M Bhujwalla

http://www.w3.org/2001/XMLSchema#string

P2860

Tumors: wounds that do not heal-redux

A role for G-CSF and GM-CSF in nonmyeloid cancers

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.

Angiogenesis in cancer and other diseases

Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment

Triple-Negative Breast Cancer

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

TIMP-1 Increases Expression and Phosphorylation of Proteins Associated with Drug Resistance in Breast Cancer Cells

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.

P2888

P304

39460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP39460

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Aleksander S. Popel

P577

2016-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007781503

http://www.w3.org/2001/XMLSchema#string

P698

27995973

http://www.w3.org/2001/XMLSchema#string

P921

P932

5171865

http://www.w3.org/2001/XMLSchema#string